Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Lopinavir/Ritonavir Monotherapy Versus Standard Highly Active Antiretroviral Therapy (HAART) in HIV/HCV Coinfected Antiretroviral (ARV) Naive Patients Starting Treatment With Anti-HCV Therapy

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified February 2009 by IRCCS San Raffaele.
Recruitment status was:  Recruiting
Sponsor:
Collaborators:
Abbott
Hoffmann-La Roche
Information provided by:
IRCCS San Raffaele
ClinicalTrials.gov Identifier:
NCT00437476
First received: February 20, 2007
Last updated: February 5, 2009
Last verified: February 2009
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: December 2010
  Estimated Primary Completion Date: July 2010 (Final data collection date for primary outcome measure)